Metabolic Fuels Study

July 19, 2017 updated by: David S. Ludwig, MD, PhD, Boston Children's Hospital

A Mechanistic Examination of Dietary Composition on Metabolic Fuels Availability

This study will evaluate a potential physiologic mechanism underlying the effects of dietary composition on control of body weight

Study Overview

Detailed Description

The challenge in maintaining long-term weight loss is well known, however new research suggests diet quality may be the driving factor. A pilot study from our group demonstrated that a higher carbohydrate-containing diet was associated with lower total energy expenditure during weight loss maintenance (Ebbeling et al). These findings will be confirmed in the ongoing Framingham State Food Study (NCT02068885): Following weight loss on a standard diet, 150 overweight or obese adults (aged 18 to 65 years) will be randomized to one of three weight-loss maintenance diets varying in carbohydrate to fat ratios for 20 weeks.

However, the specific mechanisms underlying the calorie-independent effects of diet remain unclear. Another study from our group demonstrated lower energy availability (calculated based on caloric content of circulating metabolic fuel concentrations) in the fasting and late post-prandial periods in 8 overweight or obese young adults who were maintained on a low-fat (high-carbohydrate) diet (Walsh et al). We hypothesize that this lower metabolic fuel availability on a high carbohydrate diet results in part from increased anabolic changes within the adipocyte, favoring fat storage in preference to oxidation.

We will invite subjects already enrolled in the Framingham State Food Study to participate, aiming for a total of 30 subjects (with the goal of approximately equal numbers per diet group following randomization to assigned test diet in the parent study). Participants will be admitted to a research unit for a 24-hour period during weight maintenance on the test diet, during which they will undergo frequent blood sampling for the measurement of circulating metabolic fuels, hunger and satiety ratings, while consuming their assigned diet meals. Each participant will also undergo two abdominal subcutaneous fat aspiration biopsies under local anesthesia, the first immediately following weight loss (before initiating the test diet) and the second during weight maintenance, in order to perform gene expression analyses on the adipose tissue. Our main outcomes will be a comparison in energy availability (the sum of energy in the major metabolic fuels in the blood) between diet groups in the late postprandial period and changes in adipose tissue gene expression within-individuals and by diet group assignment. Other outcomes will include differences in hunger and satiety ratings, total 24-hour energy availability, and specific metabolic fuel concentrations.

Study Type

Interventional

Enrollment (Actual)

30

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Massachusetts
      • Boston, Massachusetts, United States, 02118
        • Boston Medical Center
      • Boston, Massachusetts, United States, 02115
        • Brigham & Women's Hospital
      • Boston, Massachusetts, United States, 02115
        • Boston Children's Hospital
      • Framingham, Massachusetts, United States, 01702
        • Framingham State University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 65 years (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Inclusion Criteria:

Inclusion Criteria (as detailed in Framingham State Food Study, NCT02068885)

  • Aged 18 to 65 years
  • BMI ≥ 25 kg/m2
  • BMI < 40 kg/m2 and weight ≤ 300 lbs (136 kg)
  • Medical clearance from a primary care provider
  • Student or employee at Framingham State University throughout enrollment in the study
  • Willing and able to eat and drink only the foods and beverages on the study menus
  • Willing to eat in the dining hall
  • Willing to abstain from consuming alcohol during participation

Additional Inclusion Criteria:

• Willing to undergo additional procedures in this ancillary study

Exclusion Criteria:

Exclusion Criteria (as detailed in Framingham State Food Study, NCT02068885)

  • Change in body weight exceeding ±10% during prior year
  • Recent adherence to a special diet
  • Recent adherence to a vigorous physical activity regimen (e.g., participation in a varsity sport)
  • Chronic use of any medication or dietary supplement that could affect study outcomes
  • Current smoking (1 cigarette in the last week)
  • Heavy baseline alcohol consumption or history of binge drinking
  • Physician diagnosis of a major medical/psychiatric illness or eating disorder
  • Abnormal blood glucose, TSH, CBC, BUN, Creatinine
  • ALT greater than 150% of the normal upper limit
  • Plans for a vacation during the study that would preclude adherence to prescribed diet
  • Additional exclusions for female participants: Irregular menstrual cycles; any change in birth control medication during the 3 months prior to enrollment; pregnancy or lactation during the 12 months prior to enrollment

Additional Exclusion Criteria:

  • Allergy or prior reaction to Lidocaine
  • Medical condition or medication that would increase risk of bleeding, infection or skin reactions

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Basic Science
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Low carbohydrate diet
Composition (by proportion of calories) : 15% carbohydrate, 65% fat, 20% protein
Other Names:
  • Composition : 15% carbohydrate, 65% fat, 20% protein
Active Comparator: Moderate carbohydrate diet
Feeding study. Composition (by proportion of calories): 40% carbohydrate, 40% fat, 20% protein
Active Comparator: High carbohydrate diet
Feeding study. Composition (by proportion of calories): 60% carbohydrate, 20% fat, 20% protein

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Late postprandial energy availability
Time Frame: 10 - 15 weeks after initiation of test diets
Post-prandial energy availability calculated as the sum, in kcal/L, of energy from circulating metabolic fuels (glucose, non-esterified fatty acids, lactate and ketoacids), as measured during a 24 hr inpatient admission. Time of interest includes 2.5 - 5 hr in the postprandial period after breakfast, lunch and dinner.
10 - 15 weeks after initiation of test diets

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Late postprandial energy availability, with lactate excluded
Time Frame: 10 - 15 weeks after initiation of test diets
Post-prandial energy availability calculated as the sum, in kcal/L, of energy from circulating metabolic fuels (glucose, non-esterified fatty acids, and ketoacids), as measured during a 24 hr inpatient admission. Time of interest includes 2.5 - 5 hr in the postprandial period after breakfast, lunch and dinner. (Lactate is metabolized primarily by the liver, which uses this substrate to produce glucose. Thus, including lactate in the calculation of metabolic fuels may comprise "double counting" -- and not accurately reflect actual fuel availability to body tissues)
10 - 15 weeks after initiation of test diets
Fasting energy availability
Time Frame: 10 - 15 weeks after initiation of test diet
Fasting energy availability calculated as the sum, in kcal/L, of energy from circulating metabolic fuels (glucose, non-esterified fatty acids, lactate and ketoacids), as measured during a 24 hr inpatient admission.
10 - 15 weeks after initiation of test diet
Total energy availability
Time Frame: 10 - 15 weeks after initiation of test diets
Total energy availability calculated as the sum, in kcal/L, of energy from circulating metabolic fuels (glucose, non-esterified fatty acids, lactate and ketoacids), as measured during a 24 hr inpatient admission.
10 - 15 weeks after initiation of test diets
Hunger
Time Frame: 10 - 15 weeks after initiation of test diets
Measured during a 24 hr inpatient admission.
10 - 15 weeks after initiation of test diets
Satiety
Time Frame: 10 - 15 weeks after initiation of test diets
Measured during a 24 hr inpatient admission.
10 - 15 weeks after initiation of test diets
Glucose
Time Frame: 10 - 15 weeks after initiation of test diets
Concentration during 24-hr inpatient admission
10 - 15 weeks after initiation of test diets
Non-esterified fatty acids
Time Frame: 10 - 15 weeks after initiation after test diet
Concentration during 24-hr inpatient admission
10 - 15 weeks after initiation after test diet
Lactate
Time Frame: 10 - 15 weeks after initiation of test diets
Concentration during 24-hr inpatient admission
10 - 15 weeks after initiation of test diets
Ketoacids
Time Frame: 10 - 15 weeks after initiation of test diets
Concentration during 24-hr inpatient admission
10 - 15 weeks after initiation of test diets
Insulin
Time Frame: 10 - 15 weeks after initiation of test diets
Concentration during 24-hr inpatient admission
10 - 15 weeks after initiation of test diets

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Effect modification by insulin secretion
Time Frame: 10 - 15 weeks after initiation of test diets
We will test for an interaction by insulin secretion (as measured by plasma insulin 30 minutes into a standard oral glucose tolerance test) of the relationship between diet and metabolic fuels concentration.
10 - 15 weeks after initiation of test diets
Adipocyte studies of anabolic status
Time Frame: 10 - 15 weeks after initiation of test diets
Adipose tissue gene expression studies (assessed by mRNA levels of selected candidate genes involved in lipid storage, fatty acid and lipid biosynthesis, angiogenesis, inflammation). Change from baseline.
10 - 15 weeks after initiation of test diets
Adipose tissue histology
Time Frame: 10 - 15 weeks after initiation of test diets
Change from baseline.
10 - 15 weeks after initiation of test diets

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

October 1, 2014

Primary Completion (Actual)

May 1, 2016

Study Completion (Actual)

May 1, 2017

Study Registration Dates

First Submitted

September 5, 2014

First Submitted That Met QC Criteria

September 5, 2014

First Posted (Estimate)

September 9, 2014

Study Record Updates

Last Update Posted (Actual)

July 21, 2017

Last Update Submitted That Met QC Criteria

July 19, 2017

Last Verified

July 1, 2017

More Information

Terms related to this study

Other Study ID Numbers

  • IRB-P00014678

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Obesity

Clinical Trials on Moderate carbohydrate diet

Subscribe